Silverback Therapeutics Aktie
WKN DE: A2QHK9 / ISIN: US82835W1080
|
06.03.2025 09:39:09
|
Biotech Stocks Facing FDA Decision In March 2025
(RTTNews) - March is recognized as Awareness Month for several diseases, including Colorectal Cancer, Cerebral Palsy, Deep Vein Thrombosis, Endometriosis, Essential Tremor, Kidney Cancer, Multiple Sclerosis, and others.
The FDA has approved five novel drugs so far this year. Now, let's take a look at the biotech stocks facing FDA decisions in March 2025.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Silverback Therapeutics Inc Registered Shsmehr Nachrichten
|
12.08.25 |
Ausblick: Silverback Therapeutics legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu scPharmaceuticals Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| scPharmaceuticals Inc Registered Shs | 4,83 | -0,33% |
|
| Silverback Therapeutics Inc Registered Shs | 9,65 | -0,72% |
|